Article info

PDF

Research paper
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Authors

  1. Correspondence to Dr Satoshi Kuwabara, Department of Neurology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; kuwabara-s{at}faculty.chiba-u.jp
View Full Text

Citation

Kuwabara S, Mori M, Misawa S on behalf of the Glovenin-I CIDP Study Group, et al
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Publication history

  • Received May 13, 2017
  • Revised June 14, 2017
  • Accepted June 19, 2017
  • First published August 2, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.